Literature DB >> 6428154

GFAP, F VIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study.

D Schiffer, M T Giordana, A Mauro, A Migheli.   

Abstract

GFAP, Factor VIII/RAg, laminin, and fibronectin were immunohistochemically investigated in 15 glioblastomas and 15 gliosarcomas . GFAP was found variably positive in the glial areas. F VIII/RAg characterizes the endothelial cells and in gliosarcomas suggests the origin of the sarcomatous component from the endothelial proliferations. Laminin separates the two components and characterizes the inner and the outer basement membranes in the vessels. It is multiplied and thickened in endothelial proliferations, while it is often fragmented in the larger vessel wall proliferations. Our observations confirm that gliosarcoma represents the last stage of a process which starts with the endothelial hyperplasia of glioblastoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428154     DOI: 10.1007/bf00697192

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  [MONSTROCELLULAR SARCOMA OF THE BRAIN].

Authors:  B BINGAS
Journal:  Arch Psychiatr Nervenkr       Date:  1964-06-01

2.  The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation.

Authors:  I FEIGIN; L B ALLEN; L LIPKIN; S W GROSS
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

3.  Ultrastructure of a composite glioma-sarcoma of the brain.

Authors:  C E Peña; R Felter
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Collagenase in the immunohistochemical demonstration of laminin, fibronectin and factor VIII/RAg in nervous tissue after fixation.

Authors:  A Mauro; A Bertolotto; I Germano; G Giaccone; M T Giordana; A Migheli; D Schiffer
Journal:  Histochemistry       Date:  1984

6.  Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein.

Authors:  J M Foidart; E W Bere; M Yaar; S I Rennard; M Gullino; G R Martin; S I Katz
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

7.  Transformation-sensitive protein with molecular weight of 45,000 secreted by mouse fibroblasts.

Authors:  G Tarone; P Ceschi; M Prat; P M Comoglio
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

8.  Neoplasms of mixed mesenchymal and neuroepithelial origin. Relation to "monstrocellular sarcoma" or "giant-celled glioblastoma".

Authors:  S Shuangshoti; M G Netsky
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

9.  Clinical and pathological study of 24 cases of gliosarcoma.

Authors:  R A Morantz; I Feigin; J Ransohoff
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

10.  Factor VII related antigen as an endothelial cell marker in benign and malignant diseases.

Authors:  M Sehested; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981
View more
  29 in total

1.  Sarcomatous proliferation of the vasculature in a subependymoma: a follow-up study of sarcomatous dedifferentiation.

Authors:  D N Louis; E T Hedley-Whyte; R L Martuza
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  DNA content and marker expression in human glioma explants.

Authors:  R D Davenport; P E McKeever
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas.

Authors:  A Mauro; A Bulfone; E Turco; D Schiffer
Journal:  Childs Nerv Syst       Date:  1991-12       Impact factor: 1.475

4.  Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

Authors:  F Slowik; K Jellinger; L Gaszó; J Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

Review 5.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material.

Authors:  P Wesseling; J J Vandersteenhoven; B T Downey; D J Ruiter; P C Burger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.

Authors:  M Higuchi; T Ohnishi; N Arita; S Hiraga; T Hayakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

9.  Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas.

Authors:  P E McKeever; J Varani; S M Papadopoulos; M Wang; J P McCoy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 10.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.